Research and clinical applications of antibody phage display in transfusion medicine

Transfusion Medicine Reviews

Volumn 15, Issue 1, 2001, Pages 35-52

  Siegel, Don L ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; MONOCLONAL ANTIBODY;

ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; BACTERIOPHAGE; BLOOD TRANSFUSION; CONFERENCE PAPER; IMMUNE RESPONSE; MOLECULAR GENETICS; PHENOTYPE;

EID: 0035180069     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1053/tmrv.2001.19950     Document Type: Conference Paper

References (100)

1. Continuous cultures of fused cells secreting antibody of predefined specificity
2. Expression and characterization of recombinant anti-Rh(D) antibodies on filamentous phage: A model system for isolating human red blood cell antibodies by repertoire cloning
3. Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface
4. Human antibodies from combinatorial libraries
5. Creating and engineering human antibodies for immunotherapy
6. Isolation of cell surface-specific human monoclonal antibodies using phage display and magnetically-activated cell sorting: Applications in immunohematology
7. Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library
8. Combinatorial immunoglobulin libraries on the surface of phage (Phabs): Rapid selection of antigen-specific Fabs
9. "Diabodies": Small bivalent and bispecific antibody fragments
10. An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability
11. Tumor localization of anti-CEA single chain Fvs: Improved targeting by non-covalent dimers
12. Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts
13. Formation of a bispecific antibody by the use of leucine zippers
14. Miniantibodies: Use of amphipathic helices to produce functional, flexibly linked dimeric Fv fragments with high avidity in Escherichia coli
15. Construction, expression, and activity of a bivalent bispecific single-chain antibody
16. Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv)
17. Construction of mono- and bivalent human single-chain Fv fragments against the D antigen in the Rh blood group: Multimerization effect on cell agglutination and application to blood typing
18. A recombinant human scFv anti-Rh(D) antibody with multiple valences using a C-terminal fragment of C4-binding protein
19. Rapid phenotyping of HPA-1a using either diabody-based hemagglutination or recombinant IgG1-based assays
20. Recombinant human antibodies: Linkage of an Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture
21. pFab-CMV, a single vector system for the rapid conversion of recombinant Fabs into whole IgG1 antibodies
22. Cloning of a human autoimmune response: Preparation and sequencing of a human anti-thyroglobulin autoantibody using a combinatorial approach
23. Human anti-self antibodies with high specificity from phage display libraries
24. Human organ-specific autoimmune disease: Molecular cloning and expression of an autoantibody gene repertoire for a major autoantigen reveals an antigenic immunodominant region and restricted immunoglobulin gene usage in the target organ
25. High affinity, thyroid-specific human autoantibodies displayed on the surface of filamentous phage use V genes similar to other autoantibodies
26. Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, the major autoantigen of primary biliary cirrhosis
27. Human autoantibody recognition of DNA
28. Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis
29. Isolation of high-affinity monomeric human anti-c-erbB- 2 single chain Fv using affinity-driven selection
30. Repertoire cloning of lupus anti-DNA autoantibodies
31. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals
32. Human combinatorial antibody libraries to hepatitis B surface antigen
33. Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity
34. Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries
35. Molecular selection of human antibodies with an unconventional bacterial B cell antigen
36. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice
37. In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain crossreactivity
38. A melanoma-specific VH antibody cloned from a fusion phage library of a vaccinated melanoma patient
39. Selection and evolution of high-affinity human anti-viral antibodies
40. Phage libraries: A new route to clinically useful antibodies
41. A model system for detection and isolation of a tumor cell surface antigen using antibody phage display
42. A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments
43. Human antibody fragments specific for human blood group antigens from a phage display library
44. Characterization of human blood group scFv antibodies derived from a V gene phage-display library
45. Construction of bacteriophage expressing mouse monoclonal Fab fragments directed against the human MN glycophorin blood group antigens
46. Phage display used for gene cloning of human recombinant antibody against the erythrocyte surface antigen, rhesus D
47. Isolation of a highly mutated human anti-B antibody from a phage-display library
48. Genetic and immunological properties of phage-displayed human anti-Rh(D) antibodies: Implications for Rh(D) epitope topology
49. Only selected light chains combine with a given heavy chain to confer specificity for a model glycopeptide antigen
50. Sequence and specificity analysis of recombinant human Fab anti-Rh D isolated by phage display
51. A molecular approach for isolating high-affinity Fab fragments that are useful in blood group serology
52. Synthesis of Rh Fv phage-antibodies using VH and VL germline genes
53. A human monoclonal antibody specific for the leucine-33 (P1A1, HPA-1a) form of platelet glycoprotein IIIa from a V gene phage display library
54. Human monoclonal Fab fragments recovered from a combinatorial library bind specifically to the platelet HPA-1a alloantigen on glycoprotein IIb-IIIa
55. Isolation of human IgG platelet autoantibodies using phage display
56. Genetic origin of IgG antibodies cloned by phage display and anti-idiotypic panning from three patients with autoimmune thrombocytopenia
57. Identification of a human heavy chain antibody fragment directed against human platelet alloantigen 1a by phage display library
58. Platelet-reactive IgG antibodies cloned by phage display and panning with IVIG from three patients with autoimmune thrombocytopenia
59. The efficient production of stable human monoclonal antibody secreting hybridomas from EBV transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner
60. Production of human monoclonal IgG and IgM antibodies with anti-D (Rh) specificity using heterohybridomas
61. Requirements for the establishment of heterohybridomas secreting monoclonal human antibody to rhesus (D) blood group antigen
62. Human monoclonal antibodies against blood group antigens
63. Human monoclonal anti-D antibodies. I. Their production, serology, quantitation, and potential use as blood grouping reagents
64. Production of stable human-mouse hybridomas secreting monoclonal antibodies against Rh D and c antigens
65. Human monoclonal anti-D secreting heterohybridomas from peripheral B lymphocytes expanded in the CD40 system
66. H gene segments in human Rh(D) red cell antibodies
67. Demonstration of seven epitopes on the Rh antigen D using human monoclonal anti-D antibodies and red cells from D categories
68. Production of large repertories of macaque mAbs to human RBCs using phage display
69. Limiting dilution analysis of Epstein Barr virus-induced immunoglobulin production
70. The production of monoclonal antibodies from human lymphocytes
71. Immunoglobulin expression by human B Iymphocytes clonally transformed by EBV
72. The EBV-hybridoma technique
73. Human lymphocytes making rheumatoid factor and antibodies to ssDNA belong to Leu-1 positive B-cell subset
74. Rescue of immunoglobulin secretion from human neoplastic lymphoid cells by somatic cell hybridization
75. Preferential retention of human chromosome 14 in mouse x human B cell hybrids
76. Man-made antibodies
77. Epstein-Barr virus susceptibility of normal human B lymphocyte populations
78. Human monoclonal antibodies in the characterization of platelet antigens
79. Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies
80. H gene segments rearranged in vitro
81. Construction of a human Ig combinatorial library from genomic V segments and synthetic CDR 3 fragments
82. Antibody fragments from a "single pot" phage display library as immunochemical reagents
83. Isolation of high affinity human antibodies directly from large synthetic repertoires
84. Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions
85. Selection of phage antibodies by binding affinity mimicking affinity maturation
86. Mimicking somatic hypermutation: Affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain
87. Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates
88. Technetium-99m radiolabeling using a phage-derived single-chain Fv with a C-terminal cysteine
89. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin
90. Cytotoxic ribonucleases and chimeras in cancer therapy
91. A recombinant antibody-interleukin 2 fusion protein suppresses growth of hepatic human neuroblastoma metastases in severe combined immunodeficiency mice
92. Construction, expression and characterisation of a single chain anti-tumour antibody (scFv)-IL- 2 fusion protein
93. Monoclonal antibody-superantigen fusion proteins: Tumor-specific agents for T-cell-based tumor therapy
94. Multiple event activation of a generic prodrug trigger by antibody catalysis
95. Influenza virus hemagglutinin-specific antibodies isolated from a combinatorial expression library are closely related to the immune response of the donor
96. Antibodies from libraries
97. Antibody engineering: Comparison of bacterial, yeast, insect and mammalian expression systems